Moderna’s coronavirus vaccine found to be nearly 95% effective in a preliminary analysis

Biotechnology firm Moderna announced that a preliminary analysis shows its experimental coronavirus vaccine is nearly 95% effective at preventing illness, including severe cases — a striking initial result that raises the prospect that the US could have two coronavirus vaccines available on a limited basis by the end of the year.

The news comes a week after pharmaceutical giant Pfizer and its German partner BioNTech lifted people’s hopes with the news that their coronavirus vaccine was more than 90 percent effective.

https://www.washingtonpost.com/health/2020/11/16/covid-moderna-vaccine/